Preventing diseases and regenerating damaged tissues, parts of an organ, or even complete organs by replicating the natural processes and mechanisms of the human body<\/strong> is the main objective of Regenerative Medicine. As \u00d3scar Mayorga, head of the Regenerative Medicine Unit at SHA, comments, \u2018By using tissues, plasma, cells or proteins from the host itself, the possible side effects<\/strong> that traditional treatments can cause are avoided<\/strong> and, in addition, recovery times are accelerated<\/strong>\u2019.<\/p>\n Until recently, the most common regenerative therapies were, and still are, carried out with stem cells or growth factors. However, at SHA, as one of the pioneers in Spain in incorporating this discipline into its medical area, we have the latest technological advances to be able to incorporate cytokines<\/strong> as well.<\/strong> As \u00d3scar says, \u2018This has allowed us to go a step further in regenerative medicine treatments with autologous platelet-rich plasma (PRP). Cytokines are low molecular weight proteins<\/strong> that have proven to be very effective in treating inflammatory conditions, such as arthritis or osteoarthritis. They are released in blood cells and platelets and are a key channel for intercellular communication<\/strong>. They also control the growth and activity of other cells of the immune system. There are two types of cytokines: pro-inflammatory cytokines, which are those that produce inflammation, and anti-inflammatory<\/strong> cytokines, which are the ones we use in regenerative treatments. The process takes about an hour, and, at SHA, we use a reagent and state-of-the-art technology<\/strong> to extract the blood plasma along with the anti-inflammatory cytokines\u2019.<\/p>\n